Keith Edwards任命了N2生物医学的首席执行官

复制到剪贴板

N2生物医学是医疗器械行业的涂层和表面处理解决方案的领先供应商,很高兴地宣布Keith Edwards已被任命为首席执行官。爱德华兹先生将承担组织各个方面的领导,并将监督N2的增长战略的实施。

Edwards先生为此作用带来了丰富的专业知识,拥有20多年的医疗器械行业的经验,特别关注骨科市场。最近,他曾担任汉密尔顿桑德,有限公司的SVP和总经理,并在此职位前担任Biocoat,Inc。的总统兼首席执行官,在他在BioCoat的作用之前,Edwards先生在众多高级管理职位担任在他五年任期期间的Biomet阁下。他是联盟学院的毕业生,参加了纽约医学院。

“Keith’s broad experience in the orthopedic space makes him an ideal fit for his role at N2, and we are thrilled to have him join at this point in N2’s evolution,” said Trevor Wahlbrink, a Partner at Ampersand Capital Partners and member of the Board of Directors. “He has a proven ability to lead innovative service companies and has personally overseen thoughtful growth and expansion within this market. Under Keith’s leadership, N2 is well-positioned to continue to bring its innovative coating and surface treatment technologies to the medical device market.”

Edwards先生评论说,“N2生物医学具有出色的表面处理,卓越的文化,以及致力于卓越和每个客户的成功。我期待在N2推进有机增长并支持我们的专业团队。“

来源:N2生物医学

相关文章



联系Bonezone.

    0.